Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
2.140
-0.120 (-5.31%)
Dec 5, 2025, 4:00 PM EST - Market closed
APUS Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 3.88 | 1.28 | 0.65 | 0.27 | 0.53 |
| Research & Development | 1.27 | - | 0.1 | 0.37 | 0.49 |
| Operating Expenses | 5.15 | 1.28 | 0.75 | 0.64 | 1.02 |
| Operating Income | -5.15 | -1.28 | -0.75 | -0.64 | -1.02 |
| Interest Expense | -0.1 | -0.12 | -0.04 | -0.03 | -0.01 |
| Interest & Investment Income | 0.07 | 0 | 0.01 | - | - |
| Pretax Income | -5.16 | -1.39 | -0.78 | -0.67 | -1.03 |
| Net Income | -5.16 | -1.39 | -0.78 | -0.67 | -1.03 |
| Net Income to Common | -5.16 | -1.39 | -0.78 | -0.67 | -1.03 |
| Shares Outstanding (Basic) | 10 | 8 | 5 | 4 | 4 |
| Shares Outstanding (Diluted) | 10 | 8 | 5 | 4 | 4 |
| Shares Change (YoY) | 29.09% | 71.89% | 19.55% | - | - |
| EPS (Basic) | -0.53 | -0.18 | -0.17 | -0.17 | -0.27 |
| EPS (Diluted) | -0.53 | -0.18 | -0.17 | -0.17 | -0.27 |
| EBIT | -5.15 | -1.28 | -0.75 | -0.64 | -1.02 |
Source: S&P Capital IQ. Standard template.
Financial Sources.